P450BM-3: A tale of two domains - Or is it three?

Steroids

Volumn 62, Issue 1, 1997, Pages 117-123

  Peterson, Julian A ^a   Sevrioukova, Irina ^a   Truan, Gilles ^a   Graham Lorence, Sandra E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450;

CONFERENCE PAPER; ELECTRON TRANSPORT; ENZYME ACTIVITY; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN DOMAIN; STEROIDOGENESIS; XENOBIOTIC METABOLISM;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; EUKARYOTA; PROKARYOTA;

EID: 0031034236     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(96)00169-9     Document Type: Conference Paper

References (33)

1. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O, Okuda K, Nebert DW (1993). The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12:1-51.
2. Narhi LO, Fulco AJ (1986). Characterization of a catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium. J Biol Chem 261: 7160-7169.
3. Miura Y, Fulco AJ (1974). (Omega-2) hydroxylation of fatty acids by a soluble system from Bacillus megaterium. J Biol Chem 249: 1880-1888.
4. Narhi LO, Fulco AJ (1982). Phenobarbital induction of a soluble cytochrome P-450-dependent fatty acid monooxygenase in Bacillus megaterium. J Biol Chem 257:2147-2150.
5. Schenkman JB, Remmer H, Estabrook RW (1967). Spectral studies of drug interaction with hepatic microsomal cytochrome. Mol Pharmacol 3:113-123.
6. Peterson JA (1971). Camphor binding by pseudomonas putida cytochrome P450. Arch Biochem Biophys 144:678-693.
7. Yong FC, King TE, Oldham S, Waterman MR, Mason HS (1970). Redox-dependent conformational changes of rabbit liver cytochrome P-450. Arch Biochem Biophys 138:96-100.
8. Wen LP, Fulco AJ (1987). Cloning of the gene encoding a catalytically self-sufficient cytochrome P-450 fatty acid monooxygenase induced by barbiturates in Bacillus megaterium and its functional expression and regulation in heterologous (Escherichia coli) and homologous (Bacillus megaterium) hosts. J Biol Chem 262:6676-6682.
9. Boddupalli SS, Estabrook RW, Peterson JA (1990). Fatty acid monooxygenation by cytochrome P-450BM-3. J Biol Chem 265: 4233-4239.
10. Boddupalli SS, Pramanik BC, Slaughter CA, Estabrook RW, Peterson JA (1992). Fatty acid monooxygenation by P450BM-3: product identification and proposed mechanisms for the sequential hydroxylation reactions. Arch Biochem Biophys 292:20-28.
11. Fruetel JA, Mackman RL, Peterson JA, Ortiz de Montellano PR (1994). Relationship of active site topology to substrate specificity for cytochrome P450terp (CYP108). J Biol Chem 269:28815-28821.
12. Capdevila JH, Wei S, Helvig C, Falck JR, Felosludtsev Y, Truan G, Graham-Lorence SE, Peterson JA (1996). The highly stereoselective oxidation of polyunsaturated fatty acids by p450BM-3. J Biol Chem (in press).
13. Narhi LO, Fulco AJ (1987). Identification and characterization of two functional domains in cytochrome P-450BM-3, a catalytically self-sufficient monooxygenase induced by barbiturates in Bacillus megaterium. J Biol Chem 262:6683-6690.
14. Boddupalli SS, Oster T, Estabrook RW, Peterson JA (1992). Reconstitution of the fatty acid hydroxylation function of cytochrome P-450BM-3 utilizing its individual recombinant nemo- and flavo-protein domains. J Biol Chem 267:10375-10380.
15. Ruettinger RT, Wen LP, Fulco AJ (1989). Coding nucleotide, 5′ regulatory, and deduced amino acid sequences of P-450BM-3, a single peptide cytochrome P-450:NADPH-P-450 reductase from Bacillus megaterium. J Biol Chem 264:10987-10995.
16. Porter TD (1991). An unusual yet strongly conserved flavoprotein reductase in bacteria and mammals. Trends Biochem Sci 16:154-158.
17. Oster T, Boddupalli S, Peterson JA (1991). Expression, purification, and properties of the flavoprotein domain of cytochrome P-450BM-3. Evidence for the importance of the amino-terminal region for FMN binding. J Biol Chem 266:22718-22725.
18. Smith GCM, Tew DG, Wolf CR (1994). Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains. Proc Natl Acad Sci USA 91:8710-8714.
19. Sevrioukova IF, Truan G, Peterson JA (1996). The flavoprotein domain of P450BM-3: expression, purification, and properties of the FAD-and FMN-binding sub-domains. Biochemistry 35:7528-7535.
20. Boddupalli SS, Hasemann CA, Ravichandran KG, Lu JY, Goldsmith EJ, Deisenhofer J, Peterson JA (1992). Crystallization and preliminary x-ray diffraction analysis of P450terp and the hemoprotein domain of P450BM-3, enzymes belonging to two distinct classes of the cytochrome P450 superfamily. Proc Natl Acad Sci USA 89:5567-5571.
21. Poulos TL, Finzel BC, Howard AJ (1987). High-resolution crystal structure of cytochrome P450cam. J Mol Biol 195:687-700.
22. Ravichandran KG, Boddupalli SS, Hasemann CA, Peterson JA, Deisenhofer J (1993). Crystal structure of hemoprotein domain of P450BM3, a prototype of microsomal P450's. Science 261:731-736.
23. Hasemann CA, Ravichandran KG, Peterson JA, Deisenhofer J (1994). Crystal structure and refinement of cytochrome P450terp at 2.3 Å resolution. J Mol Biol 236:1169-1185.
24. Poulos TL (1991). Modeling of mammalian P450s on basis of P450cam x-ray structure. Methods Enzymol 206:11-30.
25. Graham-Lorence SE, Amarneh B, White RE, Peterson JA, Simpson ER (1995). A three-dimensional model of aromatase cytochrome P450. Protein Sci 4:1065-1080.
26. Modi S, Paine MJ, Sutcliffe MJ, Lian LY, Primrose WU, Wolf CR, Roberts GC (1996). A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding. Biochemistry 35:4540-4550.
27. Modi S, Primrose WU, Boyle JM, Gibson CF, Lian LY, Roberts GC (1995). NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450cam. Biochemistry 34:8982-8988.
28. Sevrioukova IF, Shaffer C, Ballou DP, Peterson JA (1996). Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3. Biochemistry 35:7058-7068.
29. Iyanagi T, Mason HS (1973). Some properties of hepatic reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase. Biochemistry 12:2297-2308.
30. Jenkins CM, Waterman MR (1994). Flavodoxin and NADPH-flavodoxin reductase from Escherichia coli support bovine cytochrome P450c17 hydroxylase activities. J Biol Chem 269:27401-27408.
31. Lin D, Black SM, Nagahama Y, Miller WL (1993). Steroid 17 α-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase. Endocrinology 132:2498-2506.
32. Lin D, Zhang LH, Chiao E, Miller WL (1994). Modeling and mutagenesis of the active site of human P450c17. Mol Endocrinol 8:392-402.
33. Kitamura M, Buczko E, Dufau ML (1991). Dissociation of hydroxylase and lyase activities by site-directed mutagenesis of the rat P45017 α. Mol Endocrinol 5:1373-1380.